Related Experiment Video
Updated: Jul 13, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke
V Lucivero1, M Prontera, D M Mezzapesa
1Department of Neurological and Psychiatric Sciences, University of Bari, Piazza G. Cesare 12, 1-70124, Bari, Italy.
Abstract:
Accumulating data suggest that matrix metalloproteinases (MMPs), in particular MMP-2 and MMP-9, are deleterious after acute ischaemic stroke. A beneficial effect of MMPs in the repairing phases of cerebral ischaemia has also been proposed. This study investigated the relationship between MMP-2 and MMP-9 and stroke subtypes, clinical recovery and haemorrhagic transformation (HT). We measured MMP-9 and MMP-2 plasma levels in 29 patients with ischaemic stroke at days one and seven. MMP-2 levels increased only in lacunar strokes, whilst MMP-9 increased only in patients with more severe stroke. Basal MMP-2 levels were higher in patients with stable or recovering symptoms whilst MMP-9 values at day seven were correlated with worse clinical outcome. No differences related to the presence of HT were found. This study sustains a different behaviour of MMPs after ischaemic stroke. MMP-2 seems to be expressed early and related to better outcome, whilst MMP-9 seems to be late and related to more severe stroke.
Insights
Matrix metalloproteinases (MMPs) show different roles after ischaemic stroke. MMP-2 is linked to better recovery, while MMP-9 is associated with more severe stroke and worse outcomes.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, have conflicting roles post-ischaemic stroke.
- MMPs may be detrimental in acute phases but potentially beneficial during repair.
Purpose of the Study:
- To investigate the relationship between MMP-2, MMP-9 levels, and stroke characteristics.
- To explore the association with stroke subtypes, clinical recovery, and haemorrhagic transformation (HT).
Main Methods:
- Plasma levels of MMP-2 and MMP-9 were measured in 29 ischaemic stroke patients.
- Measurements were taken at day one and day seven post-stroke.
Main Results:
- MMP-2 levels increased in lacunar strokes; higher basal levels correlated with better recovery.
- MMP-9 levels increased in severe strokes; day seven levels correlated with worse clinical outcomes.
- No significant association was found between MMP levels and haemorrhagic transformation.
Conclusions:
- MMP-2 and MMP-9 exhibit distinct temporal patterns and prognostic implications after ischaemic stroke.
- MMP-2 appears to be an early marker associated with favorable outcomes.
- MMP-9 is a late marker linked to stroke severity and poorer prognosis.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Clot Retraction and Fibrinolysis
Ischemic Stroke ll: Pathophysiology
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
